APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 70 filers reported holding APYX MEDICAL CORPORATION in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,877 | +23.1% | 13,499 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $31,588 | -97.8% | 13,499 | -87.9% | 0.00% | -97.7% |
| Q4 2021 | $1,425,000 | -7.5% | 111,189 | 0.0% | 0.13% | -15.1% |
| Q3 2021 | $1,540,000 | +38.7% | 111,189 | +3.2% | 0.15% | +34.5% |
| Q2 2021 | $1,110,000 | +6.7% | 107,690 | 0.0% | 0.11% | +0.9% |
| Q1 2021 | $1,040,000 | +34.2% | 107,690 | 0.0% | 0.11% | +25.8% |
| Q4 2020 | $775,000 | +7.0% | 107,690 | -30.0% | 0.09% | -8.2% |
| Q3 2020 | $724,000 | -23.6% | 153,790 | -10.0% | 0.10% | -28.7% |
| Q2 2020 | $948,000 | +51.2% | 170,790 | -2.3% | 0.14% | +29.5% |
| Q1 2020 | $627,000 | -57.6% | 174,790 | 0.0% | 0.10% | -42.3% |
| Q4 2019 | $1,479,000 | +16.6% | 174,790 | -6.7% | 0.18% | +8.3% |
| Q3 2019 | $1,268,000 | -23.7% | 187,350 | -24.3% | 0.17% | -24.7% |
| Q2 2019 | $1,662,000 | -11.4% | 247,350 | -16.8% | 0.22% | -15.2% |
| Q1 2019 | $1,876,000 | – | 297,350 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 3,452,030 | $11,046,496 | 2.90% |
| AIGH Capital Management LLC | 1,895,231 | $6,064,739 | 2.87% |
| Taylor Frigon Capital Management LLC | 621,147 | $1,987,670 | 1.10% |
| Worth Venture Partners, LLC | 462,606 | $1,480,339 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 211,800 | $678 | 0.67% |
| PURA VIDA INVESTMENTS, LLC | 836,990 | $2,678,368 | 0.51% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 372,106 | $1,190,739 | 0.19% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 301,809 | $965,789 | 0.14% |
| RTW INVESTMENTS, LP | 1,777,194 | $5,687,021 | 0.12% |
| Legato Capital Management LLC | 140,062 | $448,198 | 0.06% |